|
Volumn 41, Issue 2, 2000, Pages 115-122
|
Clinical evaluation of rhG-CSF in patients with neutropenia induced by chemotherapy for multiple myeloma
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
GRANULOCYTE COLONY STIMULATING FACTOR;
MCNU VMP PROTOCOL;
MCNU-VMP PROTOCOL;
MELPHALAN;
NITROSOUREA DERIVATIVE;
PREDNISOLONE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
VINDESINE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
MULTIPLE MYELOMA;
NEUTROPENIA;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
FEMALE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
MALE;
MELPHALAN;
MIDDLE AGED;
MULTIPLE MYELOMA;
NEUTROPENIA;
NITROSOUREA COMPOUNDS;
PREDNISOLONE;
TREATMENT OUTCOME;
VINDESINE;
|
EID: 0034133473
PISSN: 04851439
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|